Thiotepa - 55390-030-10 - (Thiotepa)

Alphabetical Index


Drug Information of Thiotepa

Product NDC: 55390-030
Proprietary Name: Thiotepa
Non Proprietary Name: Thiotepa
Active Ingredient(s): 15    mg/1.5mL & nbsp;   Thiotepa
Administration Route(s): INTRACAVITARY; INTRAVENOUS; INTRAVESICAL
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Thiotepa

Product NDC: 55390-030
Labeler Name: Bedford Laboratories
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075547
Marketing Category: ANDA
Start Marketing Date: 20010601

Package Information of Thiotepa

Package NDC: 55390-030-10
Package Description: 1 VIAL in 1 BOX, UNIT-DOSE (55390-030-10) > 1.5 mL in 1 VIAL

NDC Information of Thiotepa

NDC Code 55390-030-10
Proprietary Name Thiotepa
Package Description 1 VIAL in 1 BOX, UNIT-DOSE (55390-030-10) > 1.5 mL in 1 VIAL
Product NDC 55390-030
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Thiotepa
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRACAVITARY; INTRAVENOUS; INTRAVESICAL
Start Marketing Date 20010601
Marketing Category Name ANDA
Labeler Name Bedford Laboratories
Substance Name THIOTEPA
Strength Number 15
Strength Unit mg/1.5mL
Pharmaceutical Classes Alkylating Activity [MoA],Alkylating Drug [EPC]

Complete Information of Thiotepa


General Information